Trial Profile
Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing Disorders (Snoring Study)
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- Sponsors Merz Pharmaceuticals GmbH
- 17 Sep 2014 New trial record